S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.09%) $0.927
USD/NOK
(0.11%) $10.85
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.06%) $92.52

Realtime updates for OliX Pharmaceuticals,Inc [226950.KQ]

Exchange: KOSDAQ
Last Updated29 Mar 2024 @ 02:30

3.03% KRW 16 650

Live Chart Being Loaded With Signals

Commentary (29 Mar 2024 @ 02:30):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

OliX Pharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases...

Stats
Today's Volume 63 912.00
Average Volume 131 249
Market Cap 274.07B
EPS KRW0 ( 2024-03-15 )
Next earnings date ( KRW0 ) 2024-05-09
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW25.83 (0.16%)

Volume Correlation

Long: 0.04 (neutral)
Short: 0.67 (moderate)
Signal:(63.422) Neutral

OliX Pharmaceuticals,Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OliX Pharmaceuticals,Inc Correlation - Currency/Commodity

The country flag -0.12
( neutral )
The country flag -0.26
( neutral )
The country flag 0.09
( neutral )
The country flag 0.21
( neutral )
The country flag 0.12
( neutral )
The country flag 0.09
( neutral )

OliX Pharmaceuticals,Inc Financials

Annual 2023
Revenue: KRW17.06B
Gross Profit: KRW14.42B (84.52 %)
EPS: KRW-1 323.81
Q4 2023
Revenue: KRW10.51B
Gross Profit: KRW9.84B (93.66 %)
EPS: KRW199.43
Q3 2023
Revenue: KRW2.03B
Gross Profit: KRW1.36B (67.05 %)
EPS: KRW-345.96
Q2 2023
Revenue: KRW2.28B
Gross Profit: KRW1.61B (70.61 %)
EPS: KRW-645.58

Financial Reports:

No articles found.

OliX Pharmaceuticals,Inc

OliX Pharmaceuticals, Inc., a clinical stage biotechnology company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company's products pipeline includes OLX101 for skin scar; OLX102 for skin whitening; OLX103, an atopic dermatitis product; OLX104 for hair loss; OLX105, an anti-wrinkle product; and OLX106 for diabetic foot ulcer. Its products pipeline also comprise OLX301 for age-related macular degeneration retinal fibrosis; OLX304 for retinitis pigmentosa; OLX201 for lung fibrosis; OLX202 for asthma; OLX203 for influenza; OLX401 for neuropathic pain; OLX701 for liver fibrosis; and OLX701 for cancer immunotherapy. The company has a collaboration agreement with Théa to develop SiRNA therapeutics for ophthalmic diseases; and a research collaboration with PCI Biotech Holding ASA. OliX Pharmaceuticals, Inc. was founded in 2010 and is based in Suwon, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators